Publications by authors named "Jennifer Bacik"

Claim this Profile
P
Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma.
Premal H Patel, G Varuni Kondagunta, Lawrence Schwartz, Nicole Ishill, Jennifer Bacik

Invest New Drugs· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors.
G Varuni Kondagunta, Jennifer Bacik, Joel Sheinfeld, Dean Bajorin, Manjit Bains

J Clin Oncol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
Robert J Motzer, Craig J Nichols, Kim A Margolin, Jennifer Bacik, Paul G Richardson

J Clin Oncol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcome for metastatic papillary renal cell carcinoma patients.
Ellen A Ronnen, G Varuni Kondagunta, Nicole Ishill, Lesley Spodek, Paul Russo, Jennifer Bacik

Cancer· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma.
Ellen A Ronnen, G Varuni Kondagunta, Nicole Ishill, Suzanne M Sweeney, John K Deluca, Jennifer Bacik

Invest New Drugs· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A brief symptom index for advanced renal cell carcinoma.
David T Eton, David Cella, Jennifer Bacik, Robert J Motzer

Health Qual Life Outcomes· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sunitinib in patients with metastatic renal cell carcinoma.
Robert J Motzer, Brian I Rini, Ronald M Bukowski, Brendan D Curti, Daniel J George, Jennifer Bacik

JAMA· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors.
G Varuni Kondagunta, Jennifer Bacik, Dean Bajorin, Deborah Dobrzynski, Joel Sheinfeld

J Clin Oncol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presentation and subsequent publication rates of phase I oncology clinical trials.
Luis H Camacho, Jennifer Bacik, Alexander Cheung, David R Spriggs

Cancer· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy.
Ellen A Ronnen, G Varuni Kondagunta, Jennifer Bacik, Stephanie Marion, Dean F Bajorin

J Clin Oncol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
G Varuni Kondagunta, Jennifer Bacik, Alessia Donadio, Dean Bajorin, Stephanie Marion

J Clin Oncol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer.
Larissa K Temple, Jennifer Bacik, Salvatore G Savatta, Lester Gottesman, Philip B Paty

Dis Colon Rectum· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of bortezomib for patients with advanced renal cell carcinoma.
G Varuni Kondagunta, Beverly Drucker, Lawrence Schwartz, Jennifer Bacik, Stephanie Marion

J Clin Oncol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for survival of patients with stage IV renal cell carcinoma: memorial sloan-kettering cancer center experience.
Robert J Motzer, Jennifer Bacik, Madhu Mazumdar

Clin Cancer Res· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors.
Sanjay Koul, James M McKiernan, Gopeshwar Narayan, Jane Houldsworth, Jennifer Bacik

Mol Cancer· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors.
G Varuni Kondagunta, Jennifer Bacik, Lawrence Schwartz, Joel Sheinfeld, Dean Bajorin

Invest New Drugs· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma.
Robert J Motzer, Jennifer Bacik, Lawrence H Schwartz, Victor Reuter, Paul Russo

J Clin Oncol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy.
G Varuni Kondagunta, Joel Sheinfeld, Madhu Mazumdar, Tania V Mariani, Dean Bajorin, Jennifer Bacik

J Clin Oncol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome.
James M McKiernan, Robert J Motzer, Dean F Bajorin, Jennifer Bacik, George J Bosl

Urology· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of ZD1839 (IRESSA) in patients with advanced renal cell carcinoma.
Beverly Drucker, Jennifer Bacik, Michelle Ginsberg, Stephanie Marion, Paul Russo

Invest New Drugs· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
Madhu Mazumdar, Jennifer Bacik, Satish K Tickoo, Deborah Dobrzynski, Alessia Donadio

J Clin Oncol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods for categorizing a prognostic variable in a multivariable setting.
Madhu Mazumdar, Alex Smith, Jennifer Bacik

Stat Med· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology.
Robert J Motzer, Jennifer Bacik, Tania Mariani, Paul Russo, Madhu Mazumdar

J Clin Oncol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of thalidomide for patients with advanced renal cell carcinoma.
Robert J Motzer, William Berg, Michelle Ginsberg, Paul Russo, Jacqueline Vuky, Jennifer Bacik

J Clin Oncol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testicular seminoma: a clinicopathologic and immunohistochemical study of 105 cases with special reference to seminomas with atypical features.
Satish K Tickoo, Brian Hutchinson, Jennifer Bacik, Madhu Mazumdar, Robert J Motzer

Int J Surg Pathol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis